Atossa Therapeutics, Inc. (ATOS)
1.595
-0.16
(-8.86%)
USD |
NASDAQ |
Nov 20, 16:00
1.62
+0.02
(+1.57%)
After-Hours: 20:00
Atossa Therapeutics Price : 1.595 for Nov. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | 1.72 | 1.72 | 1.59 | 1.595 | 48922.00 |
| Nov 19, 2026 | 1.83 | 1.85 | 1.75 | 1.75 | 26211.00 |
| Nov 18, 2026 | 1.85 | 1.92 | 1.79 | 1.81 | 44435.00 |
| Nov 17, 2026 | 1.90 | 2.003 | 1.842 | 1.90 | 46525.00 |
| Nov 16, 2026 | 1.98 | 2.09 | 1.86 | 1.93 | 69553.00 |
| Nov 13, 2026 | 1.91 | 2.000 | 1.85 | 1.96 | 56355.00 |
| Nov 12, 2026 | 2.03 | 2.059 | 1.81 | 1.94 | 91514.00 |
| Nov 11, 2026 | 2.17 | 2.189 | 2.03 | 2.03 | 41464.00 |
| Nov 10, 2026 | 2.12 | 2.31 | 2.075 | 2.14 | 55558.00 |
| Nov 09, 2026 | 2.15 | 2.20 | 2.112 | 2.13 | 40224.00 |
| Nov 06, 2026 | 1.99 | 2.190 | 1.99 | 2.12 | 34833.00 |
| Nov 05, 2026 | 2.12 | 2.121 | 1.98 | 2.02 | 75034.00 |
| Nov 04, 2026 | 2.33 | 2.350 | 2.10 | 2.12 | 70259.00 |
| Nov 03, 2026 | 2.31 | 2.35 | 2.27 | 2.33 | 26079.00 |
| Nov 02, 2026 | 2.21 | 2.40 | 2.205 | 2.30 | 65998.00 |
| Oct 30, 2026 | 2.25 | 2.43 | 2.14 | 2.17 | 32904.00 |
| Oct 29, 2026 | 2.35 | 2.375 | 2.22 | 2.23 | 68008.00 |
| Oct 28, 2026 | 2.38 | 2.425 | 2.36 | 2.37 | 29463.00 |
| Oct 27, 2026 | 2.44 | 2.628 | 2.37 | 2.38 | 24835.00 |
| Oct 26, 2026 | 2.58 | 2.58 | 2.40 | 2.45 | 35078.00 |
| Oct 23, 2026 | 2.74 | 2.85 | 2.60 | 2.60 | 77025.00 |
| Oct 22, 2026 | 2.49 | 2.77 | 2.46 | 2.72 | 90656.00 |
| Oct 21, 2026 | 2.53 | 2.585 | 2.38 | 2.53 | 189632.0 |
| Oct 20, 2026 | 2.54 | 2.67 | 2.51 | 2.54 | 36755.00 |
| Oct 19, 2026 | 2.66 | 2.76 | 2.51 | 2.56 | 80522.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 17.11 |
| Alnylam Pharmaceuticals, Inc. | 143.82 |
| Anika Therapeutics, Inc. | 13.23 |
| Savara, Inc. | 4.26 |
| Arrowhead Pharmaceuticals, Inc. | 41.37 |
Price Related Metrics
| PEG Ratio | -0.0103 |
| Price to Book Value | 0.7322 |
| Earnings Yield | -244.5% |
| Market Cap | 15.92M |
| PEGY Ratio | -0.0103 |